These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 34787884)
1. Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19. Quagliariello V; Paccone A; Iovine M; Cavalcanti E; Berretta M; Maurea C; Canale ML; Maurea N Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6797-6812. PubMed ID: 34787884 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study. Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413 [TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines. Shiga T; Hiraide M Curr Treat Options Oncol; 2020 Mar; 21(4):27. PubMed ID: 32266582 [TBL] [Abstract][Full Text] [Related]
10. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients. Tajiri K; Aonuma K; Sekine I Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345 [TBL] [Abstract][Full Text] [Related]
11. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units]. Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680 [TBL] [Abstract][Full Text] [Related]
12. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions. Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177 [TBL] [Abstract][Full Text] [Related]
13. [Management of cardiovascular complications secondary to medical treatment of cancer]. Banke A; Polk A; Nielsen D; Videbæk L; Overgaard U; Fosbøl EL; Vaage-Nielsen M; Nielsen KM; Schou M Ugeskr Laeger; 2018 Feb; 180(7):. PubMed ID: 29465031 [TBL] [Abstract][Full Text] [Related]
14. Cardiac complications in childhood cancer survivors treated with anthracyclines. Franco VI; Lipshultz SE Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717 [TBL] [Abstract][Full Text] [Related]
20. Dexrazoxane : a review of its use for cardioprotection during anthracycline chemotherapy. Cvetković RS; Scott LJ Drugs; 2005; 65(7):1005-24. PubMed ID: 15892593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]